Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 241

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

U.S. Medical Eligibility Criteria for Contraceptive Use, 2024

Open access
Nguyen, Antoinette T., Curtis, Kathryn M., Tepper, Naomi K., Kortsmit, Katherine, Brittain, Anna W., Snyder, Emily M., Cohen, Megan A., Zapata, Lauren B., Whiteman, Maura K., Contributors, Baker, Courtney, Dethier, Divya, Garbarino, Sophia, Gold, Heather, Halper, Emma, Kapp, Nathalie, Krishna, Gopika, Meurice, Marielle, Ramer, Stephanie, Rodenhizer, Jessica, Verma, Nisha, Wright, Steffanie · 2024 · MMWR. Recommendations and Reports

Abstract

The 2024 U.S. Medical Eligibility Criteria for Contraceptive Use (U.S. MEC) comprises recommendations for the use of specific contraceptive methods by persons who have certain characteristics or medical conditions.These recommendations for health care providers were updated by CDC after review of the scientific evidence and a meeting with national experts in Atlanta, Georgia, during January 25-27, 2023.The information in this report replaces the 2016 U.S. MEC (CDC.U.S. Medical Eligibility Criteria for Contraceptive Use, 2016.MMWR 2016:65[No.RR-3]:1-103).Notable updates include 1) the addition of recommendations for persons with chronic kidney disease; 2) revisions to the recommendations for persons with certain characteristics or medical conditions (i.e., breastfeeding, postpartum, postabortion, obesity, surgery, deep venous thrombosis or pulmonary embolism with or without anticoagulant therapy, thrombophilia, superficial venous thrombosis, valvular heart disease, peripartum cardiomyopathy, systemic lupus erythematosus, high risk for HIV infection, cirrhosis, liver tumor, sickle cell disease, solid organ transplantation, and drug interactions with antiretrovirals used for prevention or treatment of HIV infection); and 3) inclusion of new contraceptive methods, including new doses or formulations of combined oral contraceptives, contraceptive patches, vaginal rings, progestin-only pills, levonorgestrel intrauterine devices, and vaginal pH modulator.The recommendations in this report are intended to serve as a source of evidence-based clinical practice guidance for health care providers.The goals of these recommendations are to remove unnecessary medical barriers to accessing and using contraception and to support the provision of person-centered contraceptive counseling and services in a noncoercive manner.Health care providers should always consider the individual clinical circumstances of each person seeking contraceptive services.This report is not intended to be a substitute for professional medical advice for individual patients; when needed, patients should seek advice from their health care providers about contraceptive use. USDepartment of Health and Human Services | Centers for Disease Control and Prevention | MMWR | August 8, 2024 | Vol.73 | No. 4through a shared decision-making process with health care providers (10-14).Because of the history of and ongoing forced sterilization and reproductive coercion in the United States among persons of racial and ethnic minority groups, persons with disabilities, and other groups that have been marginalized, it is important that persons can select the method that best meets their needs to promote reproductive autonomy (10)(11)(12).This report replaces the 2016 version of U.S. MEC (6) with new and revised recommendations, on the basis of new evidence and input from experts.This updated document uses gender-inclusive language throughout.However, when summarizing published evidence that describes study populations by specific genders, the wording of the primary studies has been maintained for accuracy.A summary of new and revised recommendations from the 2016 U.S. MEC is provided (Appendix A).Notable updates include • addition of recommendations for persons with chronic kidney disease, specifically those with nephrotic syndrome, those receiving hemodialysis, and those receiving peritoneal dialysis; • revisions to recommendations for persons with certain characteristics or medical conditions (i.e., breastfeeding, postpartum, postabortion, obesity, surgery, history of deep venous thrombosis or pulmonary embolism with or without anticoagulant therapy, thrombophilia, superficial venous thrombosis, valvular heart disease, peripartum cardiomyopathy, systemic lupus erythematosus, cirrhosis, liver tumor, sickle cell disease, and solid organ transplantation); • revisions to recommendations for persons at high risk for HIV infection (this recommendation was developed and published in 2020) (15); • revisions to recommendations for drug interactions with antiretrovirals to include prevention in addition to treatment for HIV infection (this recommendation was developed and published in 2020) (15); and • inclusion of additional contraceptive methods, including new doses or formulations of combined oral contraceptives (COCs), contraceptive patches, vaginal rings, progestinonly pills (POPs), levonorgestrel intrauterine devices (LNG-IUDs), and vaginal pH modulator.U.S. MEC recommendations are meant to serve as a source of evidence-based clinical guidance for health care providers and can support the provision of person-centered contraceptive counseling and services in a noncoercive manner.Health care providers should always consider the individual clinical circumstances of each person seeking contraceptive services.This report is not intended to be a substitute for professional medical advice for individual patients; when needed, patients should seek advice from their health car

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15585/mmwr.rr7304a1

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Cited by

See all 241

Metadata

Authors
Nguyen, A. T., Curtis, K. M., Tepper, N. K., Kortsmit, K., Brittain, A. W., Snyder, E. M., Cohen, M. A., Zapata, L. B., Whiteman, M. K., Contributors, Baker, C., Dethier, D., Garbarino, S., Gold, H., Halper, E., Kapp, N., Krishna, G., Meurice, M., Ramer, S., Rodenhizer, J., Verma, N., & Wright, S.
Venue
MMWR. Recommendations and Reports
Published
2024-08-08
Volume
73
Issue
4
Pages
1-126
ISSN
  • 1057-5987 (ISSN-L)
  • 1545-8601
OpenAlex
W4401358853
Cited by
241
References
37
FWCI
89.33
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. https://app.cochat.ai/papers/10.15585/mmwr.rr7304a1
The paper
Nguyen, A. T., Curtis, K. M., Tepper, N. K., Kortsmit, K., Brittain, A. W., Snyder, E. M., Cohen, M. A., Zapata, L. B., Whiteman, M. K., Contributors, Baker, C., Dethier, D., Garbarino, S., Gold, H., Halper, E., Kapp, N., Krishna, G., Meurice, M., Ramer, S., . . . Wright, S. (2024). U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR. Recommendations and Reports. https://doi.org/10.15585/mmwr.rr7304a1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.